Ilya Zubkov
Stock Analyst at Freedom Broker
(1.92)
# 3,189
Out of 5,182 analysts
71
Total ratings
37.1%
Success rate
-7.8%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Initiates: Buy | $12 | $6.20 | +93.55% | 1 | Apr 7, 2026 | |
| ANGO AngioDynamics | Initiates: Buy | $16 | $10.34 | +54.74% | 1 | Apr 6, 2026 | |
| IRMD IRADIMED CORPORATION | Initiates: Buy | $116 | $93.05 | +24.66% | 1 | Apr 2, 2026 | |
| LFMD LifeMD | Maintains: Buy | $8 → $10 | $3.83 | +161.10% | 3 | Mar 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $100 → $105 | $55.27 | +89.98% | 2 | Mar 2, 2026 | |
| BFLY Butterfly Network | Maintains: Buy | $5 → $5.5 | $4.86 | +13.17% | 2 | Mar 2, 2026 | |
| LGCY Legacy Education | Maintains: Buy | $13 → $15 | $13.40 | +8.21% | 4 | Feb 24, 2026 | |
| BIIB Biogen | Maintains: Hold | $160 → $185 | $180.54 | +2.47% | 3 | Feb 23, 2026 | |
| LFVN LifeVantage | Maintains: Buy | $17 → $11 | $4.35 | +152.87% | 3 | Feb 18, 2026 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $470 → $410 | $333.39 | +22.98% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $245 → $260 | $208.42 | +24.75% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $36 | $25.71 | +40.02% | 4 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $360 → $375 | $348.22 | +7.69% | 2 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,050 → $1,200 | $905.03 | +32.59% | 4 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $110 | $117.90 | -6.70% | 3 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $33 | $27.19 | +21.37% | 2 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $130 → $120 | $101.56 | +18.16% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $190 → $220 | $238.67 | -7.82% | 4 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $610 | $468.36 | +30.24% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $16 → $4 | $5.24 | -23.66% | 2 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $8.65 | +4.05% | 1 | Dec 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.79 | +67.60% | 1 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1 | $0.17 | +484.80% | 2 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.15 | +171.84% | 2 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $5.66 | +165.02% | 2 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $4.5 | $1.09 | +312.84% | 3 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $45.09 | -15.72% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.87 | +109.06% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $9.5 → $1 | $0.84 | +18.67% | 1 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.93 | +207.17% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $4 | $1.32 | +203.03% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 → $37 | $21.73 | +70.27% | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $15 → $1.5 | $5.30 | -71.70% | 1 | May 16, 2025 |
Inogen
Apr 7, 2026
Initiates: Buy
Price Target: $12
Current: $6.20
Upside: +93.55%
AngioDynamics
Apr 6, 2026
Initiates: Buy
Price Target: $16
Current: $10.34
Upside: +54.74%
IRADIMED CORPORATION
Apr 2, 2026
Initiates: Buy
Price Target: $116
Current: $93.05
Upside: +24.66%
LifeMD
Mar 12, 2026
Maintains: Buy
Price Target: $8 → $10
Current: $3.83
Upside: +161.10%
BioMarin Pharmaceutical
Mar 2, 2026
Maintains: Buy
Price Target: $100 → $105
Current: $55.27
Upside: +89.98%
Butterfly Network
Mar 2, 2026
Maintains: Buy
Price Target: $5 → $5.5
Current: $4.86
Upside: +13.17%
Legacy Education
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $15
Current: $13.40
Upside: +8.21%
Biogen
Feb 23, 2026
Maintains: Hold
Price Target: $160 → $185
Current: $180.54
Upside: +2.47%
LifeVantage
Feb 18, 2026
Maintains: Buy
Price Target: $17 → $11
Current: $4.35
Upside: +152.87%
Alnylam Pharmaceuticals
Feb 17, 2026
Upgrades: Buy
Price Target: $470 → $410
Current: $333.39
Upside: +22.98%
Feb 17, 2026
Maintains: Buy
Price Target: $245 → $260
Current: $208.42
Upside: +24.75%
Feb 12, 2026
Maintains: Buy
Price Target: $34 → $36
Current: $25.71
Upside: +40.02%
Feb 12, 2026
Downgrades: Hold
Price Target: $360 → $375
Current: $348.22
Upside: +7.69%
Feb 10, 2026
Upgrades: Buy
Price Target: $1,050 → $1,200
Current: $905.03
Upside: +32.59%
Feb 9, 2026
Maintains: Hold
Price Target: $90 → $110
Current: $117.90
Upside: -6.70%
Feb 9, 2026
Maintains: Buy
Price Target: $35 → $33
Current: $27.19
Upside: +21.37%
Jan 29, 2026
Upgrades: Buy
Price Target: $130 → $120
Current: $101.56
Upside: +18.16%
Jan 27, 2026
Maintains: Hold
Price Target: $190 → $220
Current: $238.67
Upside: -7.82%
Jan 26, 2026
Upgrades: Buy
Price Target: $560 → $610
Current: $468.36
Upside: +30.24%
Jan 21, 2026
Downgrades: Sell
Price Target: $16 → $4
Current: $5.24
Upside: -23.66%
Dec 30, 2025
Initiates: Buy
Price Target: $9
Current: $8.65
Upside: +4.05%
Dec 17, 2025
Initiates: Buy
Price Target: $3
Current: $1.79
Upside: +67.60%
Nov 21, 2025
Maintains: Buy
Price Target: $2 → $1
Current: $0.17
Upside: +484.80%
Nov 21, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $5.15
Upside: +171.84%
Nov 20, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $5.66
Upside: +165.02%
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $4.5
Current: $1.09
Upside: +312.84%
Oct 17, 2025
Initiates: Buy
Price Target: $38
Current: $45.09
Upside: -15.72%
Oct 1, 2025
Initiates: Buy
Price Target: $6
Current: $2.87
Upside: +109.06%
Sep 19, 2025
Downgrades: Hold
Price Target: $9.5 → $1
Current: $0.84
Upside: +18.67%
Sep 17, 2025
Initiates: Buy
Price Target: $9
Current: $2.93
Upside: +207.17%
Aug 12, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $1.32
Upside: +203.03%
Aug 11, 2025
Upgrades: Buy
Price Target: $14 → $37
Current: $21.73
Upside: +70.27%
May 16, 2025
Downgrades: Hold
Price Target: $15 → $1.5
Current: $5.30
Upside: -71.70%